Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Somatic mutations favorable to patient survival are predominant in ovarian carcinomas.

PloS one - 1 Jan 2014

Zhang Wensheng, Edwards Andrea, Flemington Erik, Zhang Kun

Abstract excerpt

Somatic mutation accumulation is a major cause of abnormal cell growth. However, some mutations in cancer cells may be deleterious to the survival and proliferation of the cancer cells, thus offering a protective effect to the patients. We investigated this hypothesis via a unique analysis of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to Carrier Proteins
Share to Gene Ontology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome, Human

Share to Models, Statistical

Share to Neoplasm Proteins

Share to Ovarian Neoplasms

Share to Survival Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 25390899
DOI: 10.1371/journal.pone.0112561
PMCID: PMC4229214

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25390899-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Somatic mutations favorable to patient survival are predominant in ovarian carcinomas.PMID 25390899Read ↗

The role of mitochondrial genes in the prognosis of ovarian cancer: new insights from bioinformaticsSemantic proximity Read ↗

Haploinsufficiency networks identify targetable patterns of allelic deficiency in low mutation ovarian cancer.Semantic proximity Read ↗

Pathway-level mutation analysis in primary high-grade serous ovarian cancer and matched brain metastases.Semantic proximity Read ↗

Tumor mutation burden forecasts outcome in ovarian cancer with BRCA1 or BRCA2 mutations.Semantic proximity Read ↗

Distinct methylation profile of mucinous ovarian carcinoma reveals susceptibility to proteasome inhibitorsSemantic proximity Read ↗

Computational identification of mutator-derived lncRNA signatures of genome instability for improving the clinical outcome of cancers: a case study in breast cancer.Semantic proximity Read ↗

Pathogenic mitochondrial DNA variants are associated with response to anti-VEGF therapy in ovarian cancer PDX models.Semantic proximity Read ↗

Discovery analysis of TCGA data reveals association between germline genotype and survival in ovarian cancer patients.Semantic proximity Read ↗

Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer.Semantic proximity Read ↗

Somatic mitochondrial DNA mutations in cancer escape purifying selection and high pathogenicity mutations lead to the oncocytic phenotype: pathogenicity analysis of reported somatic mtDNA mutations in tumors.Semantic proximity Read ↗

Mutational profiling of mitochondrial DNA reveals an epithelial ovarian cancer-specific evolutionary pattern contributing to high oxidative metabolism.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.